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ArTS & HUMANiTiES
Bradley’s Benzedrine Studies on Children with
Behavioral Disorders
Madeleine P. Strohl
History of Science/History of Medicine, Yale University, New Haven, Connecticut
in 1937, psychiatrist Charles Bradley administered Benzedrine sulfate, an amphetamine,
to “problem” children at the Emma Pendleton Bradley Home in Providence, rhode island,
in an attempt to alleviate headaches; however, Bradley noticed an unexpected effect upon
the behavior of the children: improved school performance, social interactions, and emo-
tional responses. Drawing on Bradley’s published articles on his experiments, this paper
explores the historical context of his experiments and the effect this background had on the
emerging field of child psychiatry. Bradley’s studies went largely ignored in the field of child
psychiatry for nearly 25 years. However, they proved to be an important precursor to stud-
ies of amphetamines like ritalin and their use in conditions such as attention deficit hyper-
activity disorder. Bradley’s Benzedrine trials were thus highly influential in shaping modern
objective understandings of children with behavior disorders.
INTRODUCTION
In 1937, psychiatrist Charles Bradley
administered Benzedrine sulfate, a stimu-
lant drug, to his young patients diagnosed
with  behavioral  disorders  at  the  Emma
Pendleton Bradley Home for children in
Rhode Island. After only a week, Bradley
observed:
The most striking change in be-
havior occurred in the school activi-
ties of many of these patients. There
appeared a definite “drive” to accom-
plish as much as possible. Fifteen of
the  30  children  responded  to  Ben-
zedrine by becoming distinctly sub-
dued  in  their  emotional  responses.
Clinically in all cases, this was an im-
provement from the social viewpoint
[1].
While these observations would have
resounding implications in the future treat-
ments of behavioral disorders in children,
Bradley sought to place his discovery of
these  effects  within  the  context  of  the
Emma Pendleton Bradley Home, where he
served as director [2]. The home, opened in
1931,  was  one  of  the  first  institutions
planned and equipped especially for the
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[3]. The institution took an approach that in-
tegrated both environmental and biological
treatments to go beyond simple diagnosis
and care. In contrast, the majority of behav-
iorally disturbed children at the time were
limited to either custodial care homes or
training schools [3].
Bradley experimented with Benzedrine
sulfate, a drug marketed to doctors by the
company Smith, Kline & French (SKF†) be-
tween 1935 and 1937, and published his first
study of amphetamine use for behavioral
problems in children in 1937. He hoped that
this  pharmacological  research  could  ad-
vance treatment while still upholding a firm
commitment to biological and psychologi-
cal therapy. Bradley’s studies went largely
ignored in the field of child psychiatry for
nearly 25 years; however, they proved to be
an important precursor to studies of Ritalin
and attention deficit hyperactivity disorder
(ADHD). Predominantly influenced by con-
temporary social conceptualizations of mis-
behavior and the booming industry of drug
research, Bradley’s observations on the role
of Benzedrine in children shaped our mod-
ern pharmacological understanding of chil-
dren  with  behavior  problems,  despite
Bradley’s  adamant  position  that  drugs
should only play a supporting role in treat-
ment.
THE CONCEPTUALIZATION OF 
MISBEHAVIOR
During the 19th and 20th centuries, a
new  conceptualization  of  childhood  and
how children ought to behave emerged in
both popular culture and the medical world.
A model child embodied the ideals neces-
sary for the new industrial economy: self-
regulated  behavior  and  orderly  social
relations. Childhood became the critical pe-
riod for learning restraint and developing a
proper social identity in order to grow up to
be a successful adult [4]. This prevailing
characterization of a good child generated
its opposite: the troublesome child. A broad
range of social problems fell into this cate-
gory of misbehavior and could include dif-
ficulty in schoolwork, fighting, and failure
to  obey  authority  [5].  Because  the  term
“troublesome” was so inclusive, a substan-
tial number of children fell into this cate-
gory. In response to this classification, the
child guidance movement and institutional
treatment for misbehavior originated in the
early  20th  century.  The  child  guidance
movement acted as a social reform cam-
paign that advocated for children’s mental,
material, and physical health through treat-
ments in outpatient clinics that aimed to treat
a child’s social, scholastic, and familial is-
sues [4]. When children’s needs exceeded
this clinical care, families turned to physi-
cian-run residential institutions where the
children  with  behavior  problems  were
treated alongside children with neurological
diseases. 
BRADLEY’S PHILOSOPHY
The conceptualization of misbehavior
had a profound influence on Bradley’s phi-
losophy and the objectives of the Emma
Pendleton  Bradley  Home.  Bradley  was
trained  in  pediatrics  at  Harvard  Medical
School and practiced at the Babies Hospital
in New York and the Pennsylvania Hospital
before  he  arrived  at  the  home  in  1933.
Bradley believed that “more people needed
to be educated in child psychiatry” in order
to make progress in treating troubled chil-
dren [5]. Bradley emphasized a combined
biological and psychological approach to the
troubled child. This approach matched per-
fectly with the aims of the home. George
Bradley, Bradley’s great uncle, had founded
the home in 1931 as a therapeutic hospital
for children with neuropsychiatric disorders.
The home was named after George’s daugh-
ter, who suffered from disabilities associated
with encephalitis. George and his wife had
searched worldwide to find treatment for
their daughter but found few psychiatrists
and neurologists interested in pediatric care.
As a result, they willed their Providence es-
tate  to  be  transformed  into  the  Emma
Pendleton Bradley Home [6]. The home was
situated on a large piece of wooded land
with colonial brick buildings and fields for
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“openness” was necessary for treatment so
there were no problems of congestion [3].
Doctors and nurses supervised the children
during all of their daily activities such as
school and sports. While the home still used
medical  technologies  such  as  extensive
physical exams, blood tests, and shock treat-
ments, Bradley emphasized the importance
of environment as “security, encouragement,
and an outlet for self-expression” [3,5]. This
vision set the scene for the revolutionary
studies  that  Bradley  would  undertake  in
1937. 
Admit records described patients with
both social problems and mental illnesses.
The home treated a range of physical dis-
abilities, but Bradley focused on children
with behavioral disorders [3]. He described
a number of patients with a primary diagno-
sis of neurological conditions and a second-
ary diagnosis of a behavioral disorder [3].
The patients, whose hospitalization came as
a relief to their families, were described as
inattentive, restless, rambunctious, and self-
ish [5]. From his observations at the home,
Bradley formulated the belief that a healthy
child’s  behavior  conformed  “reasonably
well to accepted social standards,” while a
misbehaving child’s behavior deviated from
these standards [7]. Bradley’s attention to
the social narrative of the child’s behavioral
issues demonstrated his devotion to personal
and integrated care.
EMERGENCE OF AMPHETAMINES
The emergence of using amphetamine
drugs to treat various conditions in the 1930s
appealed to Bradley. In 1935, the pharma-
ceutical company Smith, Kline & French
acquired the amphetamine Benzedrine sul-
fate. SKF officials provided a free drug sup-
ply  to  any  interested  doctor  and
commissioned targeted studies to explore lu-
crative possibilities such as “adrenaline-like
effects” on respiration and stimulating ef-
fects on brain function [8]. SKF officials
hoped to focus on the drug’s use for mental
performance  enhancement.  For  example,
they funded a 1936 study by Matthew Motl-
itch at the New Jersey State Home for Boys,
a reform school for delinquents, to assess the
effect of amphetamine in improving stan-
dardized test scores [8]. Bradley was among
one of the volunteers who approached SKF
for experimental supplies of Benzedrine.
However, he did not intend to use ampheta-
mine as a mental performance enhancer, but
rather a treatment for severe headaches due
to pneumonencephalograms (a visualization
technique in which air or gases were intro-
duced into the spinal column) performed on
his patients [9]. The drug had no effect on
the headaches but caused a striking change
in behavior of the children as most showed
clear improvement in performance at school
[9]. Bradley saw the promise in the idea that
Benzedrine could modify behavior and de-
cided to undertake further research into this
area.
BRADLEY’S STUDIES 
Bradley’s discovery of these behavioral
effects led to two studies, one in 1937 and
another in 1941, testing Benzedrine on chil-
dren with clinically diagnosed behavioral
problems. He intended to use these studies
to place the effects of Benzedrine within the
larger context of treatment of children with
psychiatric problems. In 1937, Bradley se-
lected 30 residents of the hospital diagnosed
with behavioral disorders who were and had
already been under observation for more
than a month and then expanded to 100 pa-
tients in 1941 in order to substantiate his ob-
servations  [1,7].  In  order  to  reflect  the
demographic  of  hospital  admissions,  he
studied children aged 5 to 14, with a large
proportion of boys. Throughout the three-
week study, a nurse observed each child
closely. During the first week, the children
were not administered any drugs. In the sec-
ond week, the children were given a dose of
Benzedrine each morning. In the third and
final week, the drug was withdrawn. The
home was “adapted to the observation of
children’s behavior under controlled condi-
tions” as the patients were unaware of the
“constant observation and careful records”
that were routinely kept [1]. In this way,
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natural community without the influence of
an artificial laboratory setting.
Upon drug administration, the children
exhibited a range of social and emotional re-
sponses. First, the Benzedrine seemed to
give the students a “drive” to accomplish as
much as possible, in addition to improving
comprehension, accuracy, and output [1].
The results reinforced SKF’s previous stud-
ies of Benzedrine as a mental performance
enhancer [8]. Bradley also found it interest-
ing that these effects appeared immediately
upon drug administration and disappeared
on the first day of drug discontinuation, re-
vealing that this drug could not fundamen-
tally change behavior but only temporarily
modify it. Thus, Benzedrine could not cure
the underlying cause of behavioral prob-
lems. 
In addition to a motivational drive, the
children also showed distinct emotional re-
sponses to Benzedrine. Half of the children
in both studies exhibited a “distinctly sub-
dued” response. For example, irritable, ag-
gressive, and noisy children became more
placid, easy-going, and interested in their
surroundings [8]. Bradley noted that these
patients “appeared subdued because they
began to spend their leisure time playing
quietly or reading, whereas formerly they
had wandered aimlessly about antagonizing
and annoying others” [7]. For other children,
there were different responses, including “a
sense of well-being . . . a widening of inter-
est in all things around them, and a dimin-
ished  tendency  to  be  preoccupied  with
themselves” [1]. In contrast to those who ex-
hibited  a  subdued  response,  a  group  of
“stimulated”  children  were  more  alert,
showed more initiative, and in general were
“more self-sufficient and mature” [7]. Like
the motivational effects, these behavior re-
sults only occurred when Benzedrine was
administered.
From these observations, Bradley con-
cluded that Benzedrine had a significant ef-
fect  upon  the  children  with  behavioral
disorders. He felt a positive response meant
that the child improved from a social view-
point [1]. For example, children with isola-
tive tendencies became acceptable commu-
nity members because they exhibited greater
consideration for their peers and engaged in
“helpful activities” [7]. As for performance,
Bradley observed that these effects had both
practical and social significance as the class-
room provided an opportunity to observe a
child’s willingness to conform to a norm [5].
The single daily dose of Benzedrine affected
the  children’s  behavior  in  the  classroom
more than the efforts of teachers and insti-
tutions. Bradley also concluded that the chil-
dren  exhibited  more  socially  appropriate
behavior. The  children  who  had  become
subdued exerted “more conscious control
over their activities and the expression of
their emotions” and conducted “themselves
with increased consideration and regard for
the feelings” of others [7]. Bradley classi-
fied this remarkable improvement in behav-
ior as conforming to the “modern” ideal of
childhood. The improved child had greater
interest in contributing to society and more
orderly social relations, which allowed the
child to become a successful adult.
Despite these positive social effects,
Bradley also noticed the drug produced an
unexplained range of effects. The stimulant
drug produced subdued behavior in half the
children and stimulated behavior in the other
half. Bradley could not justify the paradox
of a stimulant drug producing a subdued re-
sponse, and he could not explain why the
drug had different effects on different chil-
dren. There appeared to be no correlations
between the effect of Benzedrine and the
conventional clinical characteristics of sex,
age, history, physical condition, and reaction
type [1]. Bradley also could not typify a
child based on his or her changes in behav-
ior. These paradoxical responses led him to
conclude that social behavior had an emo-
tional and unstable nature, which he ac-
knowledged was not a sufficient explanation
[7].
Although Benzedrine seemed to play a
significant role in behavior modification,
Bradley stressed that the drug could only
offer a supplementary approach to the treat-
ment of behavioral problems because of its
inconsistencies.  He  reflected:  “This  ap-
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ing a child’s surroundings and so removing
the sources of conflict . . . Neither can it
offer the same assurance of mental health as
do forms of psychotherapy which enable a
child to work out his emotional problems”
[7]. This conclusion followed his model of
misbehavior as both social maladjustment
and  organic  disease.  Drugs  temporarily
modified the social maladjustment but did
not change the fundamental organic disease.
Bradley’s findings also supported the role of
the home’s environment, which produced
long-term changes rather than fleeting ef-
fects. Ultimately, Bradley concluded that an
integrated approach remained superior to
treatment.
Despite the lingering paradoxical effect
of Benzedrine, Bradley’s results had a pro-
found effect on the world of drug research
and  treatment  of  children  with  behavior
problems. It opened up two areas of am-
phetamine research: the calming effect on
children’s behavior and the stimulating ef-
fect on their academic performance. Both
produced a child that fit perfectly into the
ideals of industrialism. The child became a
productive member of society with appro-
priate social behavior and improved school
performance, implying that socially unde-
sirable problems could be treated pharma-
cologically.  While  these  effects  were
temporary, the drugs produced pronounced
changes in behavior. Furthermore, since the
effect was not limited to any one type of be-
havior problem, a wide range of children
could potentially benefit from the medica-
tion. This finding implied that Benzedrine
had the potential to be marketed to a larger
audience, which would attract the attention
of pharmaceutical companies constantly in
search of the next profitable drug.
Finally, drug therapy had the potential
to modify the role both of the institution and
the physician in the course of treatment.
Bradley noted: “Distressing surroundings
cannot always be altered, and lack of facili-
ties frequently make effective psychother-
apy  impossible.  In  such  situations,  the
simple administration of a drug that pro-
duces an improved social adjustment or ac-
celerated school progress may offer consid-
erable assistance” [7]. While the home’s en-
vironmental  therapy  was  intensive  and
lengthy, drugs produced immediate effects
in any setting. In cases where quality insti-
tutional care was not possible, drug admin-
istration would be an efficient alternative.
Drug therapy would be the best option for
children without the means for institutional-
ization. However, Bradley did not believe
that institutional care should be abandoned
in any other circumstance and that it was
still the superior approach to treatment [7].
He also recognized that drug treatment dis-
tanced the patient from the doctor. Although
this therapy could free up important time for
the physician and allow him to treat more
patients, this came at the cost of a weakened
physician-patient relationship. 
BRADLEY’S INFLUENCE IN THE
SECOND HALF OF THE 20TH 
CENTURY
While these implications had important
consequences for child psychiatry, Bradley’s
studies went largely unnoticed for several
decades. Ultimately, Bradley was unable to
identify  the  organic  cause  of  behavioral
problems and failed to define the type of
problem child who would best respond to
the drug [8]. This ambiguity led other child
psychiatrists to ignore the studies while they
searched for a clear organic etiology [9].
Meanwhile, tranquilizers flourished as the
predominant drug treatment for behavior
disorders because they produced distinct and
reproducible  responses  [10].  In  contrast,
Benzedrine produced a range of unexplained
paradoxical effects. Finally, SKF officials
ignored Bradley’s work because it focused
on children with brain defects, and the com-
pany wanted to market the drug to a larger
audience of healthy schoolchildren. More-
over, in the late 1930s, the use of ampheta-
mine for mental performance enhancement
garnered public criticism when newspapers
reported  student  abuse  scandals  and  the
medical community reported some people
had developed an addiction. Responding to
criticism, SKF officials decided to discour-
31 Strohl: Bradley’s Benzedrine studies on childrenage new research with Benzedrine, and it
was abandoned as a treatment for behavioral
disorders for the time being [8].
Nonetheless, Bradley’s work did have a
significant  impact  in  the  world  of  psy-
chopharmacology and diagnostic classifica-
tion. Bradley essentially opened up the field
of clinical research on children with behav-
ioral disorders by establishing a scientific
model for observing and experimenting with
stimulant drugs. Children with various emo-
tional and behavioral problems were well-es-
tablished clinical entities by the late 1950s,
and classifications of their behavior led to
new standards for diagnosis and treatment
[10]. Amphetamines and related stimulant
drugs would not be used as a regular treat-
ment of “misbehavior” until the 1950s, when
psychiatrists began to focus on the specific
behavioral disorder of hyperactivity. At this
point, other child psychiatrists such as Mau-
rice W. Laufer, Bradley’s successor at the
Bradley Home, took up the abandoned stud-
ies of amphetamines and sought to under-
stand their mechanism of action on children
with behavioral disorders [9]. While scien-
tists could not identify the biological mech-
anism, the Benzedrine experiments created a
scientific model for further research on stim-
ulant drugs to treat hyperactivity. In 1956,
psychiatrists  began  to  prescribe  Ritalin
(methylphenidate), a stimulant drug similar
to Benzedrine with known benefits for chil-
dren’s behavior and few side effects [10]. Fi-
nally,  in  1980,  the  DSM-III  gave  the
behavioral disorder of hyperactivity its cur-
rent name: attention deficit hyperactivity dis-
order  [9].  Like  Bradley’s  reports  on  his
patients in the home, the ADHD diagnosis
uses both medical and behavioral descrip-
tions.  Contemporary  treatment  of ADHD
fundamentally relies on stimulant drugs such
as Ritalin and Adderall, confirming the in-
fluence of Bradley’s work [11].
CONCLUSION
Built upon a new conceptualization of
misbehavior and a growing drug industry in
the early 20th century, Bradley’s studies of
Benzedrine and its effect upon children with
behavioral problems helped create the mod-
ern pharmacological approach to treating
misbehavior. However, Bradley’s work was
important beyond its role in studying and
treating troubled children and anticipating
the use of Ritalin. Bradley recognized that
these drug treatments had the greater impli-
cation of distancing the relationship between
patient and physician, a problem that chal-
lenged his philosophical emphasis on inte-
grated institutional treatment. Furthermore,
he noted that Benzedrine only temporarily
modified  behavior  rather  than  producing
permanent change. In light of these obser-
vations, Bradley was adamant that drugs
should only play a supporting role in a ho-
listic approach to treatment. Bradley did not
foresee the extent to which modern psychi-
atry would focus only on the potential of
Benzedrine’s effects and ignore Bradley’s
own conclusions. Instead, he recognized the
inherently human nature of psychiatry and
the environmental embeddedness of emo-
tions. His observation that pharmacological
solutions should always be provided in a
supportive environment and within an es-
tablished doctor-patient relationship is one
that appears particularly appealing in our
modern context. We would be wise to heed
Bradley’s call for a more nuanced use of
psychopharmacological solutions. 
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